Cargando…

Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities

BACKGROUND: Based on previous studies highlighting that the induction of cyclooxygenase-2 (COX-2) and high prostaglandin E2 (PGE2) levels contribute to the pathogenesis of malignant pleural mesothelioma (MPM), and that aromatase (CYP19A1), an enzyme that plays a key role in estrogen biosynthesis, al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuvoli, Barbara, Antoniani, Barbara, Libener, Roberta, Maconi, Antonio, Sacconi, Andrea, Carosi, Mariantonia, Galati, Rossella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369782/ https://www.ncbi.nlm.nih.gov/pubmed/34404424 http://dx.doi.org/10.1186/s13046-021-02050-1

Ejemplares similares

Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
por: Nuvoli, Barbara, et al.
Publicado: (2023)

The effect of CELLFOOD(TM) on radiotherapy or combined chemoradiotherapy: preclinical evidence
por: Nuvoli, Barbara, et al.
Publicado: (2019)

Reduction of estradiol in human malignant pleural mesothelioma tissues may prevent tumour growth, as implied by in in-vivo and in-vitro models
por: Nuvoli, Barbara, et al.
Publicado: (2016)

Reactive oxygen species a double-edged sword for mesothelioma
por: Benedetti, Serena, et al.
Publicado: (2015)

CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
por: Nuvoli, Barbara, et al.
Publicado: (2014)

Correction: CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways
por: Nuvoli, Barbara, et al.
Publicado: (2022)

Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
por: Nuvoli, Barbara, et al.
Publicado: (2014)

Retraction Note: Exemestane blocks mesothelioma growth through downregulation of cAMP, pCREB and CD44 implicating new treatment option in patients affected by this disease
por: Nuvoli, Barbara, et al.
Publicado: (2022)

Identification of Redox-Sensitive Transcription Factors as Markers of Malignant Pleural Mesothelioma
por: Schiavello, Martina, et al.
Publicado: (2021)

Epigenetic investigation into circulating microRNA 197-3p in sera from patients affected by malignant pleural mesothelioma and workers ex-exposed to asbestos
por: Di Mauro, Giulia, et al.
Publicado: (2023)

Differential diagnosis of pleural mesothelioma using Logic Learning Machine
por: Parodi, Stefano, et al.
Publicado: (2015)

Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis
por: Martarelli, Daniele, et al.
Publicado: (2006)

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
por: Stoppoloni, Daniela, et al.
Publicado: (2010)

Calcitriol Inhibits Viability and Proliferation in Human Malignant Pleural Mesothelioma Cells
por: Gesmundo, Iacopo, et al.
Publicado: (2020)

Metabolism modifications and apoptosis induction after Cellfood™ administration to leukemia cell lines
por: Catalani, Simona, et al.
Publicado: (2013)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

Precision Therapy for Mesothelioma: Feasibility and New Opportunities
por: Dulloo, Sean, et al.
Publicado: (2021)

Sera from Patients with Malignant Pleural Mesothelioma Tested Positive for IgG Antibodies against SV40 Large T Antigen: The Viral Oncoprotein
por: Mazzoni, Elisa, et al.
Publicado: (2022)

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2008)

The pathogenesis of mesothelioma is driven by a dysregulated translatome
por: Grosso, Stefano, et al.
Publicado: (2021)

New DNA Methylation Signals for Malignant Pleural Mesothelioma Risk Assessment
por: Cugliari, Giovanni, et al.
Publicado: (2021)

Retraction Note: Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability
por: Verdina, Alessandra, et al.
Publicado: (2022)

Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

DNA Methylation of FKBP5 as Predictor of Overall Survival in Malignant Pleural Mesothelioma
por: Cugliari, Giovanni, et al.
Publicado: (2020)

The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease
por: Yang, Zhihong, et al.
Publicado: (2021)

Correction to: Micro-RNA-215 and -375 regulate thymidylate synthase protein expression in pleural mesothelioma and mediate epithelial to mesenchymal transition
por: Napoli, Francesca, et al.
Publicado: (2022)

The Economic Impact of Clinical Research in an Italian Public Hospital: The Malignant Pleural Mesothelioma Case Study
por: Ippoliti, Roberto, et al.
Publicado: (2018)

Evaluation of the Preclinical Efficacy of Lurbinectedin in Malignant Pleural Mesothelioma
por: Anobile, Dario P., et al.
Publicado: (2021)

Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma
por: Hiltbrunner, Stefanie, et al.
Publicado: (2021)

Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers
por: Bononi, Ilaria, et al.
Publicado: (2016)

Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
por: Weiner, Shoshana J, et al.
Publicado: (2008)

Breast cancer metastasis: Is it a matter of OMICS and proper ex-vivo models?
por: Cioce, Mario, et al.
Publicado: (2022)

Targeting tumor-stroma communication by blocking endothelin-1 receptors sensitizes high-grade serous ovarian cancer to PARP inhibition
por: Tocci, Piera, et al.
Publicado: (2023)

Antagonists of growth hormone-releasing hormone (GHRH) inhibit the growth of human malignant pleural mesothelioma
por: Villanova, Tania, et al.
Publicado: (2019)

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
por: Sigalotti, L, et al.
Publicado: (2002)

Retraction: Pathogenesis of malignant pleural mesothelioma and the role of environmental and genetic factors
por: Weiner, Shoshana J, et al.
Publicado: (2008)

Is there a role of immunosenescence in the pathogenesis of malignant mesothelioma? A case study
por: Biswas, Abhishek
Publicado: (2016)

Tumor treating fields affect mesothelioma cell proliferation by exerting histotype-dependent cell cycle checkpoint activations and transcriptional modulations
por: Mannarino, Laura, et al.
Publicado: (2022)

New Roads Open Up for Implementing Immunotherapy in Mesothelioma
por: Cornelissen, R., et al.
Publicado: (2012)

SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma
por: Salaroglio, Iris Chiara, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0fru19q1d02tnkqprs0ks5amia